CONVERTIBLE PROMISSORY NOTEThar Pharmaceuticals Inc • August 19th, 2016 • Pharmaceutical preparations • Delaware
Company FiledAugust 19th, 2016 Industry JurisdictionFor value received, Thar Pharmaceuticals, Inc., a Delaware corporation (together with its successors and assigns, the “Company”), promises to pay to (the “Holder”), unless this Note is earlier prepaid pursuant to Section 1.3 or earlier converted pursuant to Section 2, the principal sum of Dollars ($ ), together with any and all interest accrued but unpaid thereon. This Note is one of the series of Notes issued pursuant to that certain Note and Warrant Purchase Agreement dated as of August 19, 2014, by and among the Company and the Purchasers listed in Schedule A thereto (as the same may be amended from time to time, the “Agreement”). In addition to the terms and conditions of the Agreement, this Note is subject to the following terms and conditions.
CONVERTIBLE PROMISSORY NOTEThar Pharmaceuticals Inc • April 13th, 2016 • Pharmaceutical preparations • Delaware
Company FiledApril 13th, 2016 Industry JurisdictionFor value received, Thar Pharmaceuticals, Inc., a Delaware corporation (together with its successors and assigns, the “Company”), promises to pay to (the “Holder”), unless this Note is earlier prepaid pursuant to Section 1.3 or earlier converted pursuant to Section 2, the principal sum of Dollars ($ ), together with any and all interest accrued but unpaid thereon. This Note is one of the series of Notes issued pursuant to that certain Note and Warrant Purchase Agreement dated as of August 19, 2014, by and among the Company and the Purchasers listed in Schedule A thereto (as the same may be amended from time to time, the “Agreement”). In addition to the terms and conditions of the Agreement, this Note is subject to the following terms and conditions.